China Universal Asset Management Company
MYGN icon

China Universal Asset Management Company’s Myriad Genetics MYGN Stock Holding History

China Universal Asset Management Company’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,468
Closed -$478K – 514
2024
Q3 		$478K Buy
17,468
+6,834
+64% +$185K 0.05% 226
2024
Q2 		$260K Sell
10,634
-6,606
-38% -$145K 0.04% 206
2024
Q1 		$368K Buy
17,240
+6,987
+68% +$150K 0.05% 211
2023
Q4 		$196K Buy
10,253
+8,152
+388% +$141K 0.04% 207
2023
Q3 		$33.7K Buy
2,101
+1,032
+97% +$19.6K 0.01% 257
2023
Q2 		$24.8K Sell
1,069
-29
-3% -$633 0.01% 246
2023
Q1 		$25.5K Buy
1,098
+275
+33% +$5.58K 0.01% 198
2022
Q4 		$11.9K Buy
823
+68
+9% +$1.27K ﹤0.01% 212
2022
Q3 		$14K Buy
+755
New +$17.3K 0.01% 180

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Camber Capital Management
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Disciplined Growth Investors
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

China Universal Asset Management Company's MYGN Position: Q4 2024 in Review

China Universal Asset Management Company sold out of Myriad Genetics (MYGN) in Q4 2024, closing a stake of 17,468 shares — an estimated $478K sold.

China Universal Asset Management Company first reported a position in MYGN in Q3 2022 and held it in 9 quarters. The position peaked at $478K in Q3 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2024.

  • China Universal Asset Management Company reported no remaining Myriad Genetics position as of Q4 2024 after selling out during the quarter.
  • China Universal Asset Management Company sold 17,468 Myriad Genetics shares in Q4 2024, an estimated $478K.
  • China Universal Asset Management Company first reported a position in Myriad Genetics in Q3 2022 and held it in 9 quarters.
  • China Universal Asset Management Company's Myriad Genetics position peaked at $478K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2024.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.